COURSERA INC (COUR)

US22266M1045 - Common Stock

8.71  +0.18 (+2.11%)

After market: 8.71 0 (0%)

Fundamental Rating

4

COUR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 70 industry peers in the Diversified Consumer Services industry. COUR has a great financial health rating, but its profitability evaluates not so good. COUR has a decent growth rate and is not valued too expensively.



2

1. Profitability

1.1 Basic Checks

COUR had positive earnings in the past year.
In the past year COUR had a positive cash flow from operations.
In the past 5 years COUR always reported negative net income.
In multiple years COUR reported negative operating cash flow during the last 5 years.

1.2 Ratios

COUR has a Return On Assets of -8.56%. This is comparable to the rest of the industry: COUR outperforms 41.27% of its industry peers.
COUR has a Return On Equity (-13.19%) which is in line with its industry peers.
Industry RankSector Rank
ROA -8.56%
ROE -13.19%
ROIC N/A
ROA(3y)-15.44%
ROA(5y)-16.41%
ROE(3y)-21.25%
ROE(5y)-24.72%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

COUR has a Gross Margin of 53.37%. This is in the better half of the industry: COUR outperforms 63.49% of its industry peers.
COUR's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for COUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.53%
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
COUR has more shares outstanding than it did 1 year ago.
COUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

COUR has an Altman-Z score of 2.28. This is not the best score and indicates that COUR is in the grey zone with still only limited risk for bankruptcy at the moment.
COUR's Altman-Z score of 2.28 is fine compared to the rest of the industry. COUR outperforms 65.08% of its industry peers.
COUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.28
ROIC/WACCN/A
WACC12.35%

2.3 Liquidity

A Current Ratio of 2.61 indicates that COUR has no problem at all paying its short term obligations.
COUR's Current ratio of 2.61 is fine compared to the rest of the industry. COUR outperforms 73.02% of its industry peers.
A Quick Ratio of 2.61 indicates that COUR has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.61, COUR is doing good in the industry, outperforming 74.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.61
Quick Ratio 2.61

6

3. Growth

3.1 Past

COUR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 490.24%, which is quite impressive.
Looking at the last year, COUR shows a quite strong growth in Revenue. The Revenue has grown by 12.38% in the last year.
COUR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.39% yearly.
EPS 1Y (TTM)490.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1100%
Revenue 1Y (TTM)12.38%
Revenue growth 3Y29.39%
Revenue growth 5YN/A
Sales Q2Q%6.37%

3.2 Future

The Earnings Per Share is expected to grow by 188.50% on average over the next years. This is a very strong growth
COUR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.51% yearly.
EPS Next Y1608.9%
EPS Next 2Y339.49%
EPS Next 3Y188.5%
EPS Next 5YN/A
Revenue Next Year9.66%
Revenue Next 2Y8.12%
Revenue Next 3Y8.07%
Revenue Next 5Y7.51%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 27.22 indicates a quite expensive valuation of COUR.
COUR's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of COUR to the average of the S&P500 Index (27.40), we can say COUR is valued inline with the index average.
A Price/Forward Earnings ratio of 25.05 indicates a quite expensive valuation of COUR.
COUR's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of COUR to the average of the S&P500 Index (23.67), we can say COUR is valued inline with the index average.
Industry RankSector Rank
PE 27.22
Fwd PE 25.05

4.2 Price Multiples

63.49% of the companies in the same industry are more expensive than COUR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 23.96
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as COUR's earnings are expected to grow with 188.50% in the coming years.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y339.49%
EPS Next 3Y188.5%

0

5. Dividend

5.1 Amount

No dividends for COUR!.
Industry RankSector Rank
Dividend Yield N/A

COURSERA INC

NYSE:COUR (1/6/2025, 4:34:51 PM)

After market: 8.71 0 (0%)

8.71

+0.18 (+2.11%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)10-24 2024-10-24/amc
Earnings (Next)01-30 2025-01-30/amc
Inst Owners83.74%
Inst Owner Change0%
Ins Owners5.53%
Ins Owner Change0.45%
Market Cap1.38B
Analysts77.14
Price Target10.57 (21.35%)
Short Float %5.69%
Short Ratio2.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)512.97%
Min EPS beat(2)356%
Max EPS beat(2)669.94%
EPS beat(4)4
Avg EPS beat(4)2593.7%
Min EPS beat(4)356%
Max EPS beat(4)8185%
EPS beat(8)8
Avg EPS beat(8)1337.34%
EPS beat(12)10
Avg EPS beat(12)895.72%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)1.57%
Revenue beat(4)2
Avg Revenue beat(4)-0.26%
Min Revenue beat(4)-2.75%
Max Revenue beat(4)1.57%
Revenue beat(8)6
Avg Revenue beat(8)1.24%
Revenue beat(12)9
Avg Revenue beat(12)0.86%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.17%
PT rev (3m)-34.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-36.99%
EPS NY rev (1m)0.73%
EPS NY rev (3m)46.66%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.87%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-1.16%
Valuation
Industry RankSector Rank
PE 27.22
Fwd PE 25.05
P/S 2.02
P/FCF 23.96
P/OCF 15.73
P/B 2.33
P/tB 2.41
EV/EBITDA N/A
EPS(TTM)0.32
EY3.67%
EPS(NY)0.35
Fwd EY3.99%
FCF(TTM)0.36
FCFY4.17%
OCF(TTM)0.55
OCFY6.36%
SpS4.32
BVpS3.75
TBVpS3.62
PEG (NY)0.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.56%
ROE -13.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.37%
FCFM 8.41%
ROA(3y)-15.44%
ROA(5y)-16.41%
ROE(3y)-21.25%
ROE(5y)-24.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.53%
GM growth 5YN/A
F-Score6
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 123.01%
Cap/Sales 4.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.61
Quick Ratio 2.61
Altman-Z 2.28
F-Score6
WACC12.35%
ROIC/WACCN/A
Cap/Depr(3y)93.52%
Cap/Depr(5y)118.58%
Cap/Sales(3y)3.3%
Cap/Sales(5y)3.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)490.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1100%
EPS Next Y1608.9%
EPS Next 2Y339.49%
EPS Next 3Y188.5%
EPS Next 5YN/A
Revenue 1Y (TTM)12.38%
Revenue growth 3Y29.39%
Revenue growth 5YN/A
Sales Q2Q%6.37%
Revenue Next Year9.66%
Revenue Next 2Y8.12%
Revenue Next 3Y8.07%
Revenue Next 5Y7.51%
EBIT growth 1Y37.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year207.32%
EBIT Next 3Y62.08%
EBIT Next 5Y40.15%
FCF growth 1Y220.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y375.83%
OCF growth 3YN/A
OCF growth 5YN/A